Odds of COVID‐19‐associated asthma exacerbations in children higher during Omicron wave

Abstract

AbstractBackgroundWe aimed to determine the association of COVID‐19 variant wave with asthma exacerbations in children with asthma.MethodsWe conducted a retrospective cross‐sectional study of children in the Western Pennsylvania COVID‐19 Registry (WPACR). We extracted data for all children in the WPACR with asthma and compared their acute clinical presentation and outcomes during the Pre‐Delta (7/1/20–6/30/21), Delta (8/1/21–12/14/21), and Omicron (12/15/21–8/30/22) waves. We conducted multivariable logistic regression analyses of SARS‐CoV‐2‐associated asthma exacerbations, adjusting for characteristics that have been associated with COVID‐19 outcomes in prior studies.ResultsAmong 573 children with asthma in the WPACR during the study period, the proportion of children with COVID‐19 who had an asthma exacerbation was higher during the Omicron wave than during the prior two variant waves (40.2% vs. 22.6% vs. 26.2%, p = 0.002; unadjusted OR = 2.12 [95% confidence interval (CI) = 1.39–3.22], p < 0.001). In our multivariable regression models, the odds of an asthma exacerbation were 2.8 times higher during the Omicron wave than during prior waves (adjusted OR = 2.80 [95% CI = 1.70–4.61]). Results were similar after additionally adjusting for asthma severity but were no longer significant after additionally adjusting for poor asthma control.ConclusionThe proportion of children with asthma experiencing an asthma exacerbation during SARS‐CoV‐2 infection was higher during Omicron than prior variant waves, adding to the body of evidence that COVID‐19‐associated respiratory symptoms vary by variant. These findings provide additional support for vaccination and prevention.